Summary
StemVax Therapeutics
Founded in 2014
Description
StemVax is a biopharmaceutical company developing novel immunotherapies to treat brain tumor patients. StemVax is an Innovest Global Partner, IVST.
Strengths
- There are no known strengths for StemVax Therapeutics
Weaknesses
- StemVax Therapeutics has a very small market share in their industry
- Revenue generated per employee is less than the industry average
- Revenue growth is less than the industry average
- The number of employees is not growing as fast as the industry average
- Variance of revenue growth is more than the industry average
- Since StemVax Therapeutics was founded, the company has experienced slower revenue growth than the industry average
Annual Revenue
StemVax Therapeutics's annual revenue
$781000
Based on Kona Equity data
-
Revenue per employee
$195250
-
Variance of revenue growth
0.23
-
Annual revenue growth since founding
$78100
-
Revenue growth rate from first known quarter to current
-86.7%
Employee Count
4 employees
-
Employee growth rate from first known quarter to current
-86.1%
Executives
Irvin Dwain
No Title Available
d**@stemvax.comChristopher Wheeler
President
w**@stemvax.comAndrew Norris
Chief Technical Officer
n**@stemvax.comG Score - 0
The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.
Location
Unlock unlimited leads
Similar Companies
Wernig Laboratory
werniglab.org- Location: Stanford, CA
- Annual Revenue: $1.3M
- Employees: 10
- Wernig Lab is a research laboratory at Stanford University specializing in stem cell biology, regenerative medicine, reprogramming, and neuroscience. Their recent breakthrough discovery involves identifying a pool of transcription factors that can conv...
Collaborative Medicinal Development LLC
colmeddev.com- Location: Sausalito, CA
- Annual Revenue: $4.4M
- Employees: 22
- Developing Novel Therapeutics for the Treatment of Neurodegenerative Diseases & Cancer Discover CMD
kddsystems.com
kddsystems.com- Location: New York, NY
- Annual Revenue: $1.8M
- Employees: 20
Cosmo Bio USA
cosmobiousa.com- Location: Carlsbad, CA
- Annual Revenue: $1.7M
- Employees: 8
- Cosmo Bio USA provides quality life science products from leading Japanese manufacturers, to laboratories, research institutes, life science education and testing organizations throughout North America. We take pride in that our products fill a current...
Stelexis Therapeutics
stelexis.com- Founded in 2017
- Location: New York City, NY
- Annual Revenue: $1.6M
- Employees: 7
- Stelexis Therapeutics is a New York-based cancer therapeutics company that is committed to transforming cancer treatment through the discovery of novel targets aimed at the tumor's origin. They focus on identifying, isolating, and studying the earliest...
Rigel Pharmaceuticals Inc
rigel.com- Founded in 1989
- Location: South San Francisco, CA
- Annual Revenue: $77.5M
- Employees: 165
- Rigel Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to the discovery and development of novel, targeted drugs in the therapeutic areas of immunology, oncology and immuno-oncology. Rigel's pioneering research focuses on signa...
Key Information
- Name: StemVax Therapeutics
- Industry: Pharmaceutical company
- SIC: 2834; 283
- NAICS: 32541; 3254
See similar companies
-
By City Los Angeles Small Pharmaceutical company in Los Angeles Mid-size Pharmaceutical company in Los Angeles
-
By State CA Small companies in CA Small Pharmaceutical company in CA Mid-size Pharmaceutical company in CA
-
By Industry Pharmaceutical company Small Pharmaceutical company Mid-size Pharmaceutical company
-
Firmographic data Founded in 2014 SIC: 2834 SIC: 283 NAICS: 32541 NAICS: 3254 #Drug Manufacturing & Research #Pharmaceuticals #Healthcare #Biotechnology
Frequently Asked Questions
StemVax Therapeutics's headquarters are located at 617 S. Olive St., Ste. 406 Los Angeles, CA 90014.
StemVax Therapeutics's official website is stemvax.com
StemVax Therapeutics's annual revenue is $781.0 K.
StemVax Therapeutics's SIC: 2834; 283
StemVax Therapeutics's NAICS: 32541; 3254.
StemVax Therapeutics has 4 employees
